172 related articles for article (PubMed ID: 33781536)
1. Stenotrophomonas maltophilia bloodstream infections in adult recipients of umbilical cord blood transplantation.
Kimura M; Yamamoto H; Uchida N; Ogura S; Yamamuro R; Mitsuki T; Yuasa M; Kaji D; Kageyama K; Nishida A; Taya Y; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Wake A; Taniguchi S; Araoka H
Transplant Cell Ther; 2021 Mar; 27(3):269.e1-269.e7. PubMed ID: 33781536
[TBL] [Abstract][Full Text] [Related]
2. Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations.
Cho SY; Lee DG; Choi SM; Park C; Chun HS; Park YJ; Choi JK; Lee HJ; Park SH; Choi JH; Yoo JH
BMC Infect Dis; 2015 Feb; 15():69. PubMed ID: 25887489
[TBL] [Abstract][Full Text] [Related]
3. Sulfamethoxazole/trimethoprim versus fluoroquinolones for the treatment of Stenotrophomonas maltophilia bloodstream infections.
Watson L; Esterly J; Jensen AO; Postelnick M; Aguirre A; McLaughlin M
J Glob Antimicrob Resist; 2018 Mar; 12():104-106. PubMed ID: 28964955
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation.
Kikuchi M; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Sakamoto K; Kawamura K; Ishihara Y; Sato M; Ashizawa M; Terasako-Saito K; Kimura S; Yamazaki R; Kanda J; Kako S; Nishida J; Kanda Y
Transpl Infect Dis; 2015 Feb; 17(1):56-65. PubMed ID: 25580541
[TBL] [Abstract][Full Text] [Related]
5. Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population.
Gill EL; Gill CM; McEvoy C
Ann Hematol; 2024 May; 103(5):1745-1752. PubMed ID: 38453704
[TBL] [Abstract][Full Text] [Related]
6. Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study.
Wang CH; Lin JC; Lin HA; Chang FY; Wang NC; Chiu SK; Lin TY; Yang YS; Kan LP; Yang CH; Chan MC; Yeh KM
J Microbiol Immunol Infect; 2016 Jun; 49(3):378-86. PubMed ID: 25081988
[TBL] [Abstract][Full Text] [Related]
7. Rapidly progressive fatal hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in hematologic malignancy.
Araoka H; Fujii T; Izutsu K; Kimura M; Nishida A; Ishiwata K; Nakano N; Tsuji M; Yamamoto H; Asano-Mori Y; Uchida N; Wake A; Taniguchi S; Yoneyama A
Transpl Infect Dis; 2012 Aug; 14(4):355-63. PubMed ID: 22283869
[TBL] [Abstract][Full Text] [Related]
8. Predictive implications of albumin and C-reactive protein for progression to pneumonia and poor prognosis in Stenotrophomonas maltophilia bacteremia following allogeneic hematopoietic stem cell transplantation.
Harada K; Sekiya N; Konishi T; Nagata A; Yamada Y; Takezaki T; Kaito S; Kurosawa S; Sakaguchi M; Yasuda S; Sasaki S; Yoshioka K; Watakabe-Inamoto K; Igarashi A; Najima Y; Hagino T; Muto H; Kobayashi T; Doki N; Kakihana K; Sakamaki H; Ohashi K
BMC Infect Dis; 2017 Sep; 17(1):638. PubMed ID: 28938875
[TBL] [Abstract][Full Text] [Related]
9. Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections.
Wang YL; Scipione MR; Dubrovskaya Y; Papadopoulos J
Antimicrob Agents Chemother; 2014; 58(1):176-82. PubMed ID: 24145530
[TBL] [Abstract][Full Text] [Related]
10. Bloodstream infections in adult patients undergoing cord blood transplantation from unrelated donors after myeloablative conditioning regimen.
Sanz J; Cano I; González-Barberá EM; Arango M; Reyes J; Montesinos P; Lorenzo I; Jarque I; Martínez J; López F; Arilla MJ; Lancharro A; Moscardó F; López-Hontangas JL; Salavert M; Sanz MA; Sanz GF
Biol Blood Marrow Transplant; 2015 Apr; 21(4):755-60. PubMed ID: 25585274
[TBL] [Abstract][Full Text] [Related]
11. Stenotrophomonas maltophilia bacteremia and pneumonia at a tertiary-care oncology center: a review of 16 years.
Velázquez-Acosta C; Zarco-Márquez S; Jiménez-Andrade MC; Volkow-Fernández P; Cornejo-Juárez P
Support Care Cancer; 2018 Jun; 26(6):1953-1960. PubMed ID: 29307014
[TBL] [Abstract][Full Text] [Related]
12. Bloodstream infection caused by Stenotrophomonas maltophilia in children.
Kagen J; Zaoutis TE; McGowan KL; Luan X; Shah SS
Pediatr Infect Dis J; 2007 Jun; 26(6):508-12. PubMed ID: 17529868
[TBL] [Abstract][Full Text] [Related]
13. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
[TBL] [Abstract][Full Text] [Related]
14. Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor.
Mikulska M; Raiola AM; Galaverna F; Balletto E; Borghesi ML; Varaldo R; Gualandi F; Giannoni L; Pastori G; Giacobbe DR; Signori A; Del Bono V; Viscoli C; Bacigalupo A; Angelucci E
Biol Blood Marrow Transplant; 2018 Jan; 24(1):109-118. PubMed ID: 28860000
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone-resistant strains.
Kim EJ; Kim YC; Ahn JY; Jeong SJ; Ku NS; Choi JY; Yeom JS; Song YG
BMC Infect Dis; 2019 Aug; 19(1):754. PubMed ID: 31462215
[TBL] [Abstract][Full Text] [Related]
16. Appropriate antibiotic therapy is a predictor of outcome in patients with Stenotrophomonas maltophilia blood stream infection in the intensive care unit.
Lai JJ; Siu LK; Chang FY; Lin JC; Yu CM; Wu RX; Wang CH
J Microbiol Immunol Infect; 2023 Jun; 56(3):624-633. PubMed ID: 36948945
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of trimethoprim-sulfamethoxazole based combination therapy against Stenotrophomonas maltophilia: in vitro effects and clinical efficacy in cancer patients.
Araoka H; Baba M; Okada C; Abe M; Kimura M; Yoneyama A
Int J Infect Dis; 2017 May; 58():18-21. PubMed ID: 28257816
[TBL] [Abstract][Full Text] [Related]
18. The incidence, risk factors and outcomes of early bloodstream infection in patients with malignant hematologic disease after unrelated cord blood transplantation: a retrospective study.
Ge J; Yang T; Zhang L; Zhang X; Zhu X; Tang B; Wan X; Tong J; Song K; Yao W; Sun G; Sun Z; Liu H
BMC Infect Dis; 2018 Dec; 18(1):654. PubMed ID: 30545330
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics of Rapidly Progressive Fatal Hemorrhagic Pneumonia Caused by Stenotrophomonas maltophilia.
Imoto W; Yamada K; Yamairi K; Shibata W; Namikawa H; Yukawa S; Yoshii N; Nakaie K; Hirose A; Koh H; Watanabe T; Asai K; Nakamae H; Kaneko Y; Kawaguchi T; Hino M; Kakeya H
Intern Med; 2020; 59(2):193-198. PubMed ID: 31941869
[TBL] [Abstract][Full Text] [Related]
20. [Risk factors and clinical charasteristics of Stenotrophomonas maltophilia bacteremia: a comparison with bacteremia due to other glucose-non fermenters].
Hotta G; Matsumura Y; Kato K; Nakano S; Yunoki T; Yamamoto M; Nagao M; Ito Y; Takakura S; Ichiyama S
Kansenshogaku Zasshi; 2013 Sep; 87(5):596-602. PubMed ID: 24195169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]